NantKwest, Inc. (NK) Director Steve Gorlin Sells 103,841 Shares

NantKwest, Inc. (NASDAQ:NK) Director Steve Gorlin sold 103,841 shares of NantKwest stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $6.04, for a total value of $627,199.64. Following the completion of the sale, the director now owns 375,002 shares in the company, valued at $2,265,012.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Steve Gorlin also recently made the following trade(s):

  • On Tuesday, June 20th, Steve Gorlin sold 40,000 shares of NantKwest stock. The shares were sold at an average price of $7.78, for a total value of $311,200.00.

NantKwest, Inc. (NASDAQ:NK) traded down 1.00% during mid-day trading on Tuesday, reaching $5.92. The company’s stock had a trading volume of 257,313 shares. The firm’s 50 day moving average price is $5.98 and its 200 day moving average price is $4.87. NantKwest, Inc. has a 52 week low of $4.35 and a 52 week high of $9.60. The firm’s market capitalization is $470.28 million.

TRADEMARK VIOLATION NOTICE: “NantKwest, Inc. (NK) Director Steve Gorlin Sells 103,841 Shares” was posted by Stock Observer and is the property of of Stock Observer. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.thestockobserver.com/2017/09/12/nantkwest-inc-nk-director-steve-gorlin-sells-103841-shares.html.

A number of analysts recently weighed in on the company. Citigroup Inc. set a $3.00 price target on NantKwest and gave the company a “sell” rating in a research note on Monday, August 14th. BidaskClub downgraded NantKwest from a “hold” rating to a “sell” rating in a research note on Tuesday, August 8th. Zacks Investment Research downgraded NantKwest from a “buy” rating to a “hold” rating in a research note on Wednesday, July 12th. Finally, ValuEngine upgraded NantKwest from a “strong sell” rating to a “sell” rating in a research note on Wednesday, June 14th. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $5.94.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in NantKwest by 8.4% during the 1st quarter. Vanguard Group Inc. now owns 2,082,706 shares of the biotechnology company’s stock valued at $7,394,000 after purchasing an additional 160,510 shares in the last quarter. Renaissance Technologies LLC boosted its stake in NantKwest by 1,884.1% during the 1st quarter. Renaissance Technologies LLC now owns 486,100 shares of the biotechnology company’s stock valued at $1,726,000 after purchasing an additional 461,600 shares in the last quarter. State Street Corp boosted its stake in NantKwest by 52.9% during the 2nd quarter. State Street Corp now owns 341,007 shares of the biotechnology company’s stock valued at $2,589,000 after purchasing an additional 117,946 shares in the last quarter. Northern Trust Corp boosted its stake in NantKwest by 67.8% during the 2nd quarter. Northern Trust Corp now owns 304,062 shares of the biotechnology company’s stock valued at $2,308,000 after purchasing an additional 122,906 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in NantKwest by 7.9% during the 1st quarter. Geode Capital Management LLC now owns 256,699 shares of the biotechnology company’s stock valued at $911,000 after purchasing an additional 18,685 shares in the last quarter. 18.82% of the stock is owned by hedge funds and other institutional investors.

About NantKwest

Receive News & Ratings for NantKwest Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantKwest Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply